3Rs Centre Utrecht
Utrecht UniversityThe mission of the 3Rs Centre Utrecht (3RCU) is to reduce the use of laboratory animals in research and education. To do so, we follow the three Rs of Replacement, Reduction and Refinement (in Dutch: 3Vs of Vervanging, Vermindering en Verfijning), with a primary focus on Replacement.
Biofabrication Facility Utrecht
Utrecht UniversityThe Biofabrication Facility Utrecht provides expertise, collaboration possibilities and equipment regarding the creation of functional tissues for biomedical research and for development towards clinical applications.
i-HUB – Plus Ultra Utrecht
Utrecht Science ParkDesigned to support the realisation of ideas, our concept Innovation HUB, or i-HUB for short, features fully-furnished labs and offices tailored to your research needs.
Find your Clinical Research & Clinical Trials facilities
Explore facilities that support the design, coordination and execution of clinical research and trials. These services help bridge scientific discoveries, patient participation and evidence-based healthcare innovation.
ICAT (Innovation Center for Advanced Therapies)
Utrecht Science ParkICAT, as part of UMC Utrecht aims to accelerate the development and clinical translation of Advanced Therapy Medicinal Products (ATMPs) by providing academia and industry with shared innovation labs, translational expertise and GMP manufacturing, combining the infrastructure and disciplines needed to bring innovative therapies from concept to patient.
Induced Pluripotent Stem Cell Facility
Utrecht Science ParkThe induced pluripotent stem cell (iPSC) facility at UMC Utrecht offers services for generation and characterization of iPSC lines from patient blood or tissue samples using Sendai reprogramming. The facility also provides iPSC differentiations into various cell types and generation of 3D microtissues for in vitro disease modelling.
Ombion Centre for Animal-free Biomedical Translation
Utrecht Science ParkOmbion Centre for Animal-Free Biomedical Translation is a centre for valorisation and dissemination of animal-free innovations and expertise. We aim to improve and accelerate the translation of new biomedical innovations to patients and users, at lower costs, and without the use of animals. We offer a professional network, courses, and labs for automation, demonstration and education.
Find your Spatial Omics facilities
Explore facilities that analyse molecular information within the spatial context of tissues. Spatial omics technologies help researchers map cells, transcripts, proteins, metabolites and other biomolecules to better understand tissue organisation, cell-to-cell interactions and disease processes.
Scinus Cell Expansion
Utrecht Science Park ZeistScinus Cell Expansion supports scalable, automated cell culture and expansion using the Osilaris bioreactor platform, helping researchers develop controlled and reproducible workflows for adherent and suspension cell culture applications.
Single Cell Discoveries
Utrecht Science ParkWe are the only transcriptomics service provider built to deliver high-quality data quickly and reliably. We are scientist-led and technology-agnostic. Our team identifies the right workflow for your research and runs single-cell, bulk, spatial RNA sequencing or bespoke projects from RNA sample to bioinformatic analysis. You receive your results within two to four weeks.
UMC Utrecht Core Flow Facility
Utrecht Science ParkThe Core Flow Facility provides and maintains flow cytometry equipment for over 150 annual users within the UMC Utrecht and external organizations.
Find your One Health facilities
Discover facilities that connect human, animal and environmental health research. These services support interdisciplinary approaches to infectious diseases, antimicrobial resistance, ecosystems, food systems and public health.
Utrecht Platform for Organoid Technology
Utrecht Science ParkUtrecht Platform for Organoid Technology (UPORT) is a central facility within the UMC Utrecht that supports the generation of ‘living biobanks’ of healthy and diseased human tissues. Such biobanks are typically generated using organoid and induced pluripotent stem cell culturing technologies. UPORT provides a logistical infrastructure for rapid and standardized acquisition of human tissues, based on approved protocols for patient inclusion.